 | • レポートコード：GIR-107A14363 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アルファ-1アンチトリプシン医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルファ-1アンチトリプシン医薬品の種類別市場規模（非経口、吸入）、用途別市場規模（ドラッグストア、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルファ-1アンチトリプシン医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Baxter、CSL Behring、Grifols、Kamada、Abeona Therapeutics、Alnylam Pharmaceuticals、Applied Genetic Technologies Corp、Arrowhead Research Corporation、Baxalta ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：非経口、吸入 ・用途別分析2016年-2026年：ドラッグストア、病院、その他 ・アルファ-1アンチトリプシン医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アルファ-1アンチトリプシン医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アルファ-1アンチトリプシン医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アルファ-1アンチトリプシン医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アルファ-1アンチトリプシン医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Alpha-1 Antitrypsin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alpha-1 Antitrypsin Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Alpha-1 Antitrypsin Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alpha-1 Antitrypsin Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Parenteral
Inhalation
Market segment by Application can be divided into
Drugstore
Hospital
Others
The key market players for global Alpha-1 Antitrypsin Drugs market are listed below:
Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Alpha-1 Antitrypsin Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alpha-1 Antitrypsin Drugs, with price, sales, revenue and global market share of Alpha-1 Antitrypsin Drugs from 2019 to 2021.
Chapter 3, the Alpha-1 Antitrypsin Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha-1 Antitrypsin Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Alpha-1 Antitrypsin Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Alpha-1 Antitrypsin Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Alpha-1 Antitrypsin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alpha-1 Antitrypsin Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Parenteral
1.2.3 Inhalation
1.3 Market Analysis by Application
1.3.1 Overview: Global Alpha-1 Antitrypsin Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Alpha-1 Antitrypsin Drugs Market Size & Forecast
1.4.1 Global Alpha-1 Antitrypsin Drugs Sales in Value (2016-2026))
1.4.2 Global Alpha-1 Antitrypsin Drugs Sales in Volume (2016-2026)
1.4.3 Global Alpha-1 Antitrypsin Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Alpha-1 Antitrypsin Drugs Production Capacity Analysis
1.5.1 Global Alpha-1 Antitrypsin Drugs Total Production Capacity (2016-2026)
1.5.2 Global Alpha-1 Antitrypsin Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alpha-1 Antitrypsin Drugs Market Drivers
1.6.2 Alpha-1 Antitrypsin Drugs Market Restraints
1.6.3 Alpha-1 Antitrypsin Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Alpha-1 Antitrypsin Drugs Product and Services
2.1.4 Baxter Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 CSL Behring
2.2.1 CSL Behring Details
2.2.2 CSL Behring Major Business
2.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Product and Services
2.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Alpha-1 Antitrypsin Drugs Product and Services
2.3.4 Grifols Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Kamada
2.4.1 Kamada Details
2.4.2 Kamada Major Business
2.4.3 Kamada Alpha-1 Antitrypsin Drugs Product and Services
2.4.4 Kamada Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Abeona Therapeutics
2.5.1 Abeona Therapeutics Details
2.5.2 Abeona Therapeutics Major Business
2.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product and Services
2.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Alnylam Pharmaceuticals
2.6.1 Alnylam Pharmaceuticals Details
2.6.2 Alnylam Pharmaceuticals Major Business
2.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product and Services
2.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Applied Genetic Technologies Corp
2.7.1 Applied Genetic Technologies Corp Details
2.7.2 Applied Genetic Technologies Corp Major Business
2.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product and Services
2.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Arrowhead Research Corporation
2.8.1 Arrowhead Research Corporation Details
2.8.2 Arrowhead Research Corporation Major Business
2.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product and Services
2.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Baxalta
2.9.1 Baxalta Details
2.9.2 Baxalta Major Business
2.9.3 Baxalta Alpha-1 Antitrypsin Drugs Product and Services
2.9.4 Baxalta Alpha-1 Antitrypsin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Alpha-1 Antitrypsin Drugs Sales by Manufacturer
3.1 Global Alpha-1 Antitrypsin Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Alpha-1 Antitrypsin Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Alpha-1 Antitrypsin Drugs Manufacturer Market Share
3.4.2 Top 6 Alpha-1 Antitrypsin Drugs Manufacturer Market Share
3.5 Global Alpha-1 Antitrypsin Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Alpha-1 Antitrypsin Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alpha-1 Antitrypsin Drugs Market Size by Region
4.1.1 Global Alpha-1 Antitrypsin Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Region (2016-2026)
4.2 North America Alpha-1 Antitrypsin Drugs Revenue (2016-2026)
4.3 Europe Alpha-1 Antitrypsin Drugs Revenue (2016-2026)
4.4 Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue (2016-2026)
4.5 South America Alpha-1 Antitrypsin Drugs Revenue (2016-2026)
4.6 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Alpha-1 Antitrypsin Drugs Sales in Volume by Type (2016-2026)
5.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2016-2026)
5.3 Global Alpha-1 Antitrypsin Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Alpha-1 Antitrypsin Drugs Sales in Volume by Application (2016-2026)
6.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2016-2026)
6.3 Global Alpha-1 Antitrypsin Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Alpha-1 Antitrypsin Drugs Sales by Type (2016-2026)
7.2 North America Alpha-1 Antitrypsin Drugs Sales by Application (2016-2026)
7.3 North America Alpha-1 Antitrypsin Drugs Market Size by Country
7.3.1 North America Alpha-1 Antitrypsin Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Alpha-1 Antitrypsin Drugs Sales by Type (2016-2026)
8.2 Europe Alpha-1 Antitrypsin Drugs Sales by Application (2016-2026)
8.3 Europe Alpha-1 Antitrypsin Drugs Market Size by Country
8.3.1 Europe Alpha-1 Antitrypsin Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size by Region
9.3.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Alpha-1 Antitrypsin Drugs Sales by Type (2016-2026)
10.2 South America Alpha-1 Antitrypsin Drugs Sales by Application (2016-2026)
10.3 South America Alpha-1 Antitrypsin Drugs Market Size by Country
10.3.1 South America Alpha-1 Antitrypsin Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Alpha-1 Antitrypsin Drugs Market Size by Country
11.3.1 Middle East & Africa Alpha-1 Antitrypsin Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Alpha-1 Antitrypsin Drugs Typical Distributors
12.3 Alpha-1 Antitrypsin Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Alpha-1 Antitrypsin Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Alpha-1 Antitrypsin Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Baxter Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Major Business
Table 5. Baxter Alpha-1 Antitrypsin Drugs Product and Services
Table 6. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 8. CSL Behring Major Business
Table 9. CSL Behring Alpha-1 Antitrypsin Drugs Product and Services
Table 10. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Grifols Basic Information, Manufacturing Base and Competitors
Table 12. Grifols Major Business
Table 13. Grifols Alpha-1 Antitrypsin Drugs Product and Services
Table 14. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Kamada Basic Information, Manufacturing Base and Competitors
Table 16. Kamada Major Business
Table 17. Kamada Alpha-1 Antitrypsin Drugs Product and Services
Table 18. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Abeona Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Abeona Therapeutics Major Business
Table 21. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product and Services
Table 22. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Alnylam Pharmaceuticals Major Business
Table 25. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product and Services
Table 26. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Applied Genetic Technologies Corp Basic Information, Manufacturing Base and Competitors
Table 28. Applied Genetic Technologies Corp Major Business
Table 29. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product and Services
Table 30. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Arrowhead Research Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Arrowhead Research Corporation Major Business
Table 33. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product and Services
Table 34. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Baxalta Basic Information, Manufacturing Base and Competitors
Table 36. Baxalta Major Business
Table 37. Baxalta Alpha-1 Antitrypsin Drugs Product and Services
Table 38. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Alpha-1 Antitrypsin Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Alpha-1 Antitrypsin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Alpha-1 Antitrypsin Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Alpha-1 Antitrypsin Drugs Production Site of Key Manufacturer
Table 44. Alpha-1 Antitrypsin Drugs New Entrant and Capacity Expansion Plans
Table 45. Alpha-1 Antitrypsin Drugs Mergers & Acquisitions in the Past Five Years
Table 46. Global Alpha-1 Antitrypsin Drugs Sales by Region (2016-2021e) & (K Units)
Table 47. Global Alpha-1 Antitrypsin Drugs Sales by Region (2021-2026) & (K Units)
Table 48. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021e) & (K Units)
Table 51. Global Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Alpha-1 Antitrypsin Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 55. Global Alpha-1 Antitrypsin Drugs Price by Type (2021-2026) & (USD/Unit)
Table 56. Global Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021e) & (K Units)
Table 57. Global Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (K Units)
Table 58. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Alpha-1 Antitrypsin Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 61. Global Alpha-1 Antitrypsin Drugs Price by Application (2021-2026) & (USD/Unit)
Table 62. North America Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021e) & (K Units)
Table 63. North America Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (K Units)
Table 64. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021e) & (K Units)
Table 67. North America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (K Units)
Table 68. North America Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021e) & (K Units)
Table 69. North America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (K Units)
Table 70. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (K Units)
Table 72. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (K Units)
Table 76. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (K Units)
Table 86. South America Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021e) & (K Units)
Table 87. South America Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (K Units)
Table 88. South America Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Alpha-1 Antitrypsin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021e) & (K Units)
Table 91. South America Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (K Units)
Table 92. South America Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021e) & (K Units)
Table 93. South America Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Alpha-1 Antitrypsin Drugs Typical Distributors
Table 105. Alpha-1 Antitrypsin Drugs Typical Customers
List of Figures
Figure 1. Alpha-1 Antitrypsin Drugs Picture
Figure 2. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020
Figure 3. Parenteral
Figure 4. Inhalation
Figure 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020
Figure 6. Drugstore
Figure 7. Hospital
Figure 8. Others
Figure 9. Global Alpha-1 Antitrypsin Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Alpha-1 Antitrypsin Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Alpha-1 Antitrypsin Drugs Sales (2016-2026) & (K Units)
Figure 12. Global Alpha-1 Antitrypsin Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Alpha-1 Antitrypsin Drugs Production Capacity (2016-2026) & (K Units)
Figure 14. Global Alpha-1 Antitrypsin Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Alpha-1 Antitrypsin Drugs Market Drivers
Figure 16. Alpha-1 Antitrypsin Drugs Market Restraints
Figure 17. Alpha-1 Antitrypsin Drugs Market Trends
Figure 18. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturer in 2020
Figure 19. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturer in 2020
Figure 20. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Alpha-1 Antitrypsin Drugs Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Alpha-1 Antitrypsin Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2016-2026)
Figure 24. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2016-2026)
Figure 25. North America Alpha-1 Antitrypsin Drugs Revenue (2016-2026) & (USD Million)
Figure 26. Europe Alpha-1 Antitrypsin Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue (2016-2026) & (USD Million)
Figure 28. South America Alpha-1 Antitrypsin Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2026)
Figure 31. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2016-2026)
Figure 32. Global Alpha-1 Antitrypsin Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2026)
Figure 34. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2016-2026)
Figure 35. Global Alpha-1 Antitrypsin Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2026)
Figure 37. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2026)
Figure 38. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2026)
Figure 39. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2026)
Figure 40. United States Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2026)
Figure 44. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2026)
Figure 45. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2026)
Figure 46. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2026)
Figure 47. Germany Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2016-2026)
Figure 56. China Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2026)
Figure 63. South America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2026)
Figure 64. South America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2026)
Figure 65. South America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
α1-アンチトリプシン(AAT)薬市場：世界及び中国市場分析・予測（～2024年） Alpha-1 Antitrypsin Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Alpha-1 Antitrypsin Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Alpha-1 Antitrypsi…- 世界のαマンノシドーシス治療市場 2021：企業別、地域別、種類・用途別 The Alpha Mannosidosis Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の良性前立腺肥大症治療薬市場 2021：企業別、地域別、種類・用途別 The Benign Prostate Hyperplasia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界のアルファ-1プロテイナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別 The Alpha-1 Proteinase Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 良性前立腺過形成薬の世界市場 2019年版：種類別（アルファブロッカー、5-アルファレダクターゼ阻害剤、ホスホジエステラーゼ-5阻害剤、その他）、用途別（病院、クリニック、その他） Description Scope of the Report: The global Benign Prostate Hyperplasia Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, …